Typical and atypical pathology in primary progressive aphasia variants

Objective To characterize in vivo signatures of pathological diagnosis in a large cohort of patients with primary progressive aphasia (PPA) variants defined by current diagnostic classification. Methods Extensive clinical, cognitive, neuroimaging, and neuropathological data were collected from 69 pa...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Annals of neurology Ročník 81; číslo 3; s. 430 - 443
Hlavní autoři:	Spinelli, Edoardo G., Mandelli, Maria Luisa, Miller, Zachary A., Santos‐Santos, Miguel A, Wilson, Stephen M., Agosta, Federica, Grinberg, Lea T., Huang, Eric J., Trojanowski, John Q., Meyer, Marita, Henry, Maya L., Comi, Giancarlo, Rabinovici, Gil, Rosen, Howard J., Filippi, Massimo, Miller, Bruce L., Seeley, William W., Gorno‐Tempini, Maria Luisa
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Wiley Subscription Services, Inc 01.03.2017
Témata:	Aged Aged, 80 and over Alzheimer Disease - classification Alzheimer Disease - pathology Alzheimer Disease - physiopathology Aphasia, Primary Progressive - classification Aphasia, Primary Progressive - pathology Aphasia, Primary Progressive - physiopathology Atrophy - pathology Female Frontotemporal Lobar Degeneration - classification Frontotemporal Lobar Degeneration - pathology Frontotemporal Lobar Degeneration - physiopathology Gray Matter - diagnostic imaging Humans Male Medical imaging Middle Aged Neuropathology Pathology Pick Disease of the Brain - pathology Pick Disease of the Brain - physiopathology Primary Progressive Nonfluent Aphasia - pathology Primary Progressive Nonfluent Aphasia - physiopathology Support Vector Machine tau Proteins - metabolism White Matter - diagnostic imaging
ISSN:	0364-5134, 1531-8249, 1531-8249
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Objective To characterize in vivo signatures of pathological diagnosis in a large cohort of patients with primary progressive aphasia (PPA) variants defined by current diagnostic classification. Methods Extensive clinical, cognitive, neuroimaging, and neuropathological data were collected from 69 patients with sporadic PPA, divided into 29 semantic (svPPA), 25 nonfluent (nfvPPA), 11 logopenic (lvPPA), and 4 mixed PPA. Patterns of gray matter (GM) and white matter (WM) atrophy at presentation were assessed and tested as predictors of pathological diagnosis using support vector machine (SVM) algorithms. Results A clinical diagnosis of PPA was associated with frontotemporal lobar degeneration (FTLD) with transactive response DNA‐binding protein (TDP) inclusions in 40.5%, FTLD‐tau in 40.5%, and Alzheimer disease (AD) pathology in 19% of cases. Each variant was associated with 1 typical pathology; 24 of 29 (83%) svPPA showed FTLD‐TDP type C, 22 of 25 (88%) nfvPPA showed FTLD‐tau, and all 11 lvPPA had AD. Within FTLD‐tau, 4R‐tau pathology was commonly associated with nfvPPA, whereas Pick disease was observed in a minority of subjects across all variants except for lvPPA. Compared with pathologically typical cases, svPPA‐tau showed significant extrapyramidal signs, greater executive impairment, and severe striatal and frontal GM and WM atrophy. nfvPPA‐TDP patients lacked general motor symptoms or significant WM atrophy. Combining GM and WM volumes, SVM analysis showed 92.7% accuracy to distinguish FTLD‐tau and FTLD‐TDP pathologies across variants. Interpretation Each PPA clinical variant is associated with a typical and most frequent cognitive, neuroimaging, and neuropathological profile. Specific clinical and early anatomical features may suggest rare and atypical pathological diagnosis in vivo. Ann Neurol 2017;81:430–443
AbstractList	To characterize in vivo signatures of pathological diagnosis in a large cohort of patients with primary progressive aphasia (PPA) variants defined by current diagnostic classification.OBJECTIVETo characterize in vivo signatures of pathological diagnosis in a large cohort of patients with primary progressive aphasia (PPA) variants defined by current diagnostic classification.Extensive clinical, cognitive, neuroimaging, and neuropathological data were collected from 69 patients with sporadic PPA, divided into 29 semantic (svPPA), 25 nonfluent (nfvPPA), 11 logopenic (lvPPA), and 4 mixed PPA. Patterns of gray matter (GM) and white matter (WM) atrophy at presentation were assessed and tested as predictors of pathological diagnosis using support vector machine (SVM) algorithms.METHODSExtensive clinical, cognitive, neuroimaging, and neuropathological data were collected from 69 patients with sporadic PPA, divided into 29 semantic (svPPA), 25 nonfluent (nfvPPA), 11 logopenic (lvPPA), and 4 mixed PPA. Patterns of gray matter (GM) and white matter (WM) atrophy at presentation were assessed and tested as predictors of pathological diagnosis using support vector machine (SVM) algorithms.A clinical diagnosis of PPA was associated with frontotemporal lobar degeneration (FTLD) with transactive response DNA-binding protein (TDP) inclusions in 40.5%, FTLD-tau in 40.5%, and Alzheimer disease (AD) pathology in 19% of cases. Each variant was associated with 1 typical pathology; 24 of 29 (83%) svPPA showed FTLD-TDP type C, 22 of 25 (88%) nfvPPA showed FTLD-tau, and all 11 lvPPA had AD. Within FTLD-tau, 4R-tau pathology was commonly associated with nfvPPA, whereas Pick disease was observed in a minority of subjects across all variants except for lvPPA. Compared with pathologically typical cases, svPPA-tau showed significant extrapyramidal signs, greater executive impairment, and severe striatal and frontal GM and WM atrophy. nfvPPA-TDP patients lacked general motor symptoms or significant WM atrophy. Combining GM and WM volumes, SVM analysis showed 92.7% accuracy to distinguish FTLD-tau and FTLD-TDP pathologies across variants.RESULTSA clinical diagnosis of PPA was associated with frontotemporal lobar degeneration (FTLD) with transactive response DNA-binding protein (TDP) inclusions in 40.5%, FTLD-tau in 40.5%, and Alzheimer disease (AD) pathology in 19% of cases. Each variant was associated with 1 typical pathology; 24 of 29 (83%) svPPA showed FTLD-TDP type C, 22 of 25 (88%) nfvPPA showed FTLD-tau, and all 11 lvPPA had AD. Within FTLD-tau, 4R-tau pathology was commonly associated with nfvPPA, whereas Pick disease was observed in a minority of subjects across all variants except for lvPPA. Compared with pathologically typical cases, svPPA-tau showed significant extrapyramidal signs, greater executive impairment, and severe striatal and frontal GM and WM atrophy. nfvPPA-TDP patients lacked general motor symptoms or significant WM atrophy. Combining GM and WM volumes, SVM analysis showed 92.7% accuracy to distinguish FTLD-tau and FTLD-TDP pathologies across variants.Each PPA clinical variant is associated with a typical and most frequent cognitive, neuroimaging, and neuropathological profile. Specific clinical and early anatomical features may suggest rare and atypical pathological diagnosis in vivo. Ann Neurol 2017;81:430-443.INTERPRETATIONEach PPA clinical variant is associated with a typical and most frequent cognitive, neuroimaging, and neuropathological profile. Specific clinical and early anatomical features may suggest rare and atypical pathological diagnosis in vivo. Ann Neurol 2017;81:430-443. Objective To characterize in vivo signatures of pathological diagnosis in a large cohort of patients with primary progressive aphasia (PPA) variants defined by current diagnostic classification. Methods Extensive clinical, cognitive, neuroimaging, and neuropathological data were collected from 69 patients with sporadic PPA, divided into 29 semantic (svPPA), 25 nonfluent (nfvPPA), 11 logopenic (lvPPA), and 4 mixed PPA. Patterns of gray matter (GM) and white matter (WM) atrophy at presentation were assessed and tested as predictors of pathological diagnosis using support vector machine (SVM) algorithms. Results A clinical diagnosis of PPA was associated with frontotemporal lobar degeneration (FTLD) with transactive response DNA-binding protein (TDP) inclusions in 40.5%, FTLD-tau in 40.5%, and Alzheimer disease (AD) pathology in 19% of cases. Each variant was associated with 1 typical pathology; 24 of 29 (83%) svPPA showed FTLD-TDP type C, 22 of 25 (88%) nfvPPA showed FTLD-tau, and all 11 lvPPA had AD. Within FTLD-tau, 4R-tau pathology was commonly associated with nfvPPA, whereas Pick disease was observed in a minority of subjects across all variants except for lvPPA. Compared with pathologically typical cases, svPPA-tau showed significant extrapyramidal signs, greater executive impairment, and severe striatal and frontal GM and WM atrophy. nfvPPA-TDP patients lacked general motor symptoms or significant WM atrophy. Combining GM and WM volumes, SVM analysis showed 92.7% accuracy to distinguish FTLD-tau and FTLD-TDP pathologies across variants. Interpretation Each PPA clinical variant is associated with a typical and most frequent cognitive, neuroimaging, and neuropathological profile. Specific clinical and early anatomical features may suggest rare and atypical pathological diagnosis in vivo. Ann Neurol 2017;81:430-443 Objective To characterize in vivo signatures of pathological diagnosis in a large cohort of patients with primary progressive aphasia (PPA) variants defined by current diagnostic classification. Methods Extensive clinical, cognitive, neuroimaging, and neuropathological data were collected from 69 patients with sporadic PPA, divided into 29 semantic (svPPA), 25 nonfluent (nfvPPA), 11 logopenic (lvPPA), and 4 mixed PPA. Patterns of gray matter (GM) and white matter (WM) atrophy at presentation were assessed and tested as predictors of pathological diagnosis using support vector machine (SVM) algorithms. Results A clinical diagnosis of PPA was associated with frontotemporal lobar degeneration (FTLD) with transactive response DNA‐binding protein (TDP) inclusions in 40.5%, FTLD‐tau in 40.5%, and Alzheimer disease (AD) pathology in 19% of cases. Each variant was associated with 1 typical pathology; 24 of 29 (83%) svPPA showed FTLD‐TDP type C, 22 of 25 (88%) nfvPPA showed FTLD‐tau, and all 11 lvPPA had AD. Within FTLD‐tau, 4R‐tau pathology was commonly associated with nfvPPA, whereas Pick disease was observed in a minority of subjects across all variants except for lvPPA. Compared with pathologically typical cases, svPPA‐tau showed significant extrapyramidal signs, greater executive impairment, and severe striatal and frontal GM and WM atrophy. nfvPPA‐TDP patients lacked general motor symptoms or significant WM atrophy. Combining GM and WM volumes, SVM analysis showed 92.7% accuracy to distinguish FTLD‐tau and FTLD‐TDP pathologies across variants. Interpretation Each PPA clinical variant is associated with a typical and most frequent cognitive, neuroimaging, and neuropathological profile. Specific clinical and early anatomical features may suggest rare and atypical pathological diagnosis in vivo. Ann Neurol 2017;81:430–443 To characterize in vivo signatures of pathological diagnosis in a large cohort of patients with primary progressive aphasia (PPA) variants defined by current diagnostic classification. Extensive clinical, cognitive, neuroimaging, and neuropathological data were collected from 69 patients with sporadic PPA, divided into 29 semantic (svPPA), 25 nonfluent (nfvPPA), 11 logopenic (lvPPA), and 4 mixed PPA. Patterns of gray matter (GM) and white matter (WM) atrophy at presentation were assessed and tested as predictors of pathological diagnosis using support vector machine (SVM) algorithms. A clinical diagnosis of PPA was associated with frontotemporal lobar degeneration (FTLD) with transactive response DNA-binding protein (TDP) inclusions in 40.5%, FTLD-tau in 40.5%, and Alzheimer disease (AD) pathology in 19% of cases. Each variant was associated with 1 typical pathology; 24 of 29 (83%) svPPA showed FTLD-TDP type C, 22 of 25 (88%) nfvPPA showed FTLD-tau, and all 11 lvPPA had AD. Within FTLD-tau, 4R-tau pathology was commonly associated with nfvPPA, whereas Pick disease was observed in a minority of subjects across all variants except for lvPPA. Compared with pathologically typical cases, svPPA-tau showed significant extrapyramidal signs, greater executive impairment, and severe striatal and frontal GM and WM atrophy. nfvPPA-TDP patients lacked general motor symptoms or significant WM atrophy. Combining GM and WM volumes, SVM analysis showed 92.7% accuracy to distinguish FTLD-tau and FTLD-TDP pathologies across variants. Each PPA clinical variant is associated with a typical and most frequent cognitive, neuroimaging, and neuropathological profile. Specific clinical and early anatomical features may suggest rare and atypical pathological diagnosis in vivo. Ann Neurol 2017;81:430-443.
Author	Grinberg, Lea T. Henry, Maya L. Mandelli, Maria Luisa Wilson, Stephen M. Trojanowski, John Q. Huang, Eric J. Rosen, Howard J. Meyer, Marita Rabinovici, Gil Seeley, William W. Miller, Zachary A. Comi, Giancarlo Filippi, Massimo Miller, Bruce L. Spinelli, Edoardo G. Gorno‐Tempini, Maria Luisa Santos‐Santos, Miguel A Agosta, Federica
AuthorAffiliation	2 Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy 4 Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA 1 Memory and Aging Center, University of California, San Francisco, CA, USA 3 Department of Speech, Language, and Hearing Sciences, University of Arizona, Tucson, AZ, USA 5 Department of Communication Sciences and Disorders, University of Texas, Austin, TX, USA
AuthorAffiliation_xml	– name: 4 Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA – name: 1 Memory and Aging Center, University of California, San Francisco, CA, USA – name: 2 Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy – name: 3 Department of Speech, Language, and Hearing Sciences, University of Arizona, Tucson, AZ, USA – name: 5 Department of Communication Sciences and Disorders, University of Texas, Austin, TX, USA
Author_xml	– sequence: 1 givenname: Edoardo G. surname: Spinelli fullname: Spinelli, Edoardo G. organization: Vita‐Salute San Raffaele University – sequence: 2 givenname: Maria Luisa surname: Mandelli fullname: Mandelli, Maria Luisa organization: University of California – sequence: 3 givenname: Zachary A. surname: Miller fullname: Miller, Zachary A. organization: University of California – sequence: 4 givenname: Miguel A surname: Santos‐Santos fullname: Santos‐Santos, Miguel A organization: University of California – sequence: 5 givenname: Stephen M. surname: Wilson fullname: Wilson, Stephen M. organization: Vanderbilt University Medical Center – sequence: 6 givenname: Federica surname: Agosta fullname: Agosta, Federica organization: Vita‐Salute San Raffaele University – sequence: 7 givenname: Lea T. surname: Grinberg fullname: Grinberg, Lea T. organization: University of California – sequence: 8 givenname: Eric J. surname: Huang fullname: Huang, Eric J. organization: University of California – sequence: 9 givenname: John Q. surname: Trojanowski fullname: Trojanowski, John Q. organization: University of Pennsylvania – sequence: 10 givenname: Marita surname: Meyer fullname: Meyer, Marita organization: University of California – sequence: 11 givenname: Maya L. surname: Henry fullname: Henry, Maya L. organization: University of Texas – sequence: 12 givenname: Giancarlo surname: Comi fullname: Comi, Giancarlo organization: Vita‐Salute San Raffaele University – sequence: 13 givenname: Gil surname: Rabinovici fullname: Rabinovici, Gil organization: University of California – sequence: 14 givenname: Howard J. surname: Rosen fullname: Rosen, Howard J. organization: University of California – sequence: 15 givenname: Massimo surname: Filippi fullname: Filippi, Massimo organization: Vita‐Salute San Raffaele University – sequence: 16 givenname: Bruce L. surname: Miller fullname: Miller, Bruce L. organization: University of California – sequence: 17 givenname: William W. surname: Seeley fullname: Seeley, William W. organization: University of California – sequence: 18 givenname: Maria Luisa surname: Gorno‐Tempini fullname: Gorno‐Tempini, Maria Luisa email: marialuisa.gornotempini@ucsf.edu organization: University of California
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/28133816$$D View this record in MEDLINE/PubMed
BookMark	eNqNkUFvEzEQhS1URNPAgT-AVuICh209u7ZjX5CiigJSBZdytibe2cTVxl7Wm6D8exyyRVCBxGlkzfeenuddsLMQAzH2EvglcF5dYcDLSmgtn7AZyBpKXQlzxma8VqKUUItzdpHSPefcKODP2Hmloa41qBm7uTv03mFXYGgKHKdHj-MmdnF9KHwo-sFvcTjkGdcDpeT3VGC_weSx2OPgMYzpOXvaYpfoxTTn7OvN-7vrj-Xtlw-frpe3pZN8IUsFBAtTiYVcOaqbVSMbhVRpAt2qnMi05KhxoBAzAS4vyTTUNqRauWqgnrN3J99-t9pmksI4YGeniDait39ugt_YddxbKSrQYLLBm8lgiN92lEa79clR12GguEsWtNZmYZTi_4GqygjJ88Xn7PUj9D7uhpAvcTTkinMhjtSr38P_Sv3QRgauToAbYkoDtdb5EUcfj3_xnQVuj33b3Lf92XdWvH2keDD9Gzu5f_cdHf4N2uXn5UnxA2sou0o
CitedBy_id	crossref_primary_10_1111_neup_12780 crossref_primary_10_1016_S1474_4422_17_30157_6 crossref_primary_10_1136_bmjopen_2025_102668 crossref_primary_10_3390_brainsci11111371 crossref_primary_10_1038_s41598_025_02020_z crossref_primary_10_1136_jnnp_2017_316402 crossref_primary_10_1212_WNL_0000000000010948 crossref_primary_10_1186_s40478_021_01129_2 crossref_primary_10_1007_s00415_019_09362_5 crossref_primary_10_1136_jnnp_2017_316409 crossref_primary_10_1159_000504938 crossref_primary_10_1016_j_neurobiolaging_2019_10_011 crossref_primary_10_3389_fnagi_2022_994750 crossref_primary_10_1002_alz_12299 crossref_primary_10_1007_s00259_018_4075_3 crossref_primary_10_3389_fneur_2022_944806 crossref_primary_10_1162_nol_a_00075 crossref_primary_10_1016_j_parkreldis_2021_09_008 crossref_primary_10_1016_j_arr_2024_102375 crossref_primary_10_1016_j_cortex_2022_10_010 crossref_primary_10_1093_brain_awad327 crossref_primary_10_1002_alz_12170 crossref_primary_10_1007_s00401_021_02402_3 crossref_primary_10_1097_WCO_0000000000000502 crossref_primary_10_1016_j_jns_2024_122998 crossref_primary_10_3233_JAD_190699 crossref_primary_10_3389_fnhum_2022_945160 crossref_primary_10_1007_s00259_022_06065_4 crossref_primary_10_1186_s13195_019_0470_7 crossref_primary_10_36833_lkl_2024_008 crossref_primary_10_3233_JAD_201210 crossref_primary_10_1177_0271678X211001216 crossref_primary_10_1080_02687038_2025_2495618 crossref_primary_10_3233_JAD_210392 crossref_primary_10_1002_dad2_12423 crossref_primary_10_1016_j_bandl_2018_09_003 crossref_primary_10_1016_j_neubiorev_2025_106194 crossref_primary_10_3389_fneur_2021_628406 crossref_primary_10_1016_j_mcn_2018_10_003 crossref_primary_10_1186_s13063_022_06162_7 crossref_primary_10_1007_s00415_020_09927_9 crossref_primary_10_1038_s41572_023_00447_0 crossref_primary_10_1212_WNL_0000000000010366 crossref_primary_10_1080_14737175_2018_1489241 crossref_primary_10_3389_fnsys_2024_1324437 crossref_primary_10_1016_j_neurobiolaging_2020_09_004 crossref_primary_10_1007_s00401_019_02035_7 crossref_primary_10_1016_j_nicl_2020_102369 crossref_primary_10_1111_ene_16370 crossref_primary_10_1002_alz_14338 crossref_primary_10_1186_s40478_022_01499_1 crossref_primary_10_1016_j_cortex_2022_05_010 crossref_primary_10_1002_trc2_12188 crossref_primary_10_1212_CON_0000000000000687 crossref_primary_10_1186_s40478_021_01229_z crossref_primary_10_1044_2023_JSLHR_23_00289 crossref_primary_10_1080_02699206_2024_2378345 crossref_primary_10_1177_08919887211036189 crossref_primary_10_1093_brain_awaa033 crossref_primary_10_1093_brain_awae196 crossref_primary_10_1016_j_disamonth_2025_101863 crossref_primary_10_1177_13872877251376381 crossref_primary_10_1007_s00415_019_09530_7 crossref_primary_10_3233_JAD_180087 crossref_primary_10_1212_WNL_0000000000213524 crossref_primary_10_3389_fnins_2018_00585 crossref_primary_10_1038_s41598_025_13000_8 crossref_primary_10_1186_s13195_018_0393_8 crossref_primary_10_3390_ijms21238948 crossref_primary_10_1080_09602011_2020_1822188 crossref_primary_10_1016_j_psycr_2022_100044 crossref_primary_10_1044_2021_AJSLP_20_00361 crossref_primary_10_3389_fnagi_2021_710818 crossref_primary_10_1002_alz_14158 crossref_primary_10_1002_mds_28517 crossref_primary_10_1186_s13195_023_01176_y crossref_primary_10_1093_brain_awaa097 crossref_primary_10_1186_s13024_022_00525_z crossref_primary_10_3233_JAD_230652 crossref_primary_10_1016_j_nicl_2021_102913 crossref_primary_10_1017_S1366728923000226 crossref_primary_10_1212_WNL_0000000000200843 crossref_primary_10_3390_brainsci12020146 crossref_primary_10_3233_JAD_200567 crossref_primary_10_3233_JAD_220272 crossref_primary_10_3389_fnagi_2021_675739 crossref_primary_10_3390_genes10120978 crossref_primary_10_1016_j_nicl_2025_103852 crossref_primary_10_1186_s13195_022_01007_6 crossref_primary_10_1097_WNN_0000000000000229 crossref_primary_10_1002_alz_13750 crossref_primary_10_1007_s00415_023_12030_4 crossref_primary_10_1007_s00401_025_02901_7 crossref_primary_10_3390_brainsci15080839 crossref_primary_10_1212_WNL_0000000000008937 crossref_primary_10_2496_hbfr_43_12 crossref_primary_10_3389_fnagi_2023_1120935 crossref_primary_10_1093_brain_awab057 crossref_primary_10_1080_09638288_2023_2199463 crossref_primary_10_1016_j_psc_2020_02_005 crossref_primary_10_1016_j_psc_2020_02_006 crossref_primary_10_1097_RLU_0000000000004853 crossref_primary_10_1016_j_cortex_2019_08_007 crossref_primary_10_1016_j_jagp_2023_08_017 crossref_primary_10_1007_s00259_022_05964_w crossref_primary_10_1038_s41598_019_42625_9 crossref_primary_10_1080_23279095_2020_1811707 crossref_primary_10_3389_fneur_2018_00766 crossref_primary_10_1080_14737175_2025_2461758 crossref_primary_10_3389_fnins_2019_00757 crossref_primary_10_1093_brain_awae314 crossref_primary_10_1093_brain_awx217 crossref_primary_10_1212_WNL_0000000000007146 crossref_primary_10_1038_s41598_020_72847_1 crossref_primary_10_1177_13872877241312932 crossref_primary_10_1097_WNN_0000000000000365 crossref_primary_10_1002_ana_25183 crossref_primary_10_1159_000508625 crossref_primary_10_3389_fnagi_2024_1448214 crossref_primary_10_1016_j_neurobiolaging_2022_05_002 crossref_primary_10_1212_WNL_0000000000012174 crossref_primary_10_1002_ana_25739 crossref_primary_10_1016_j_nicl_2017_09_007 crossref_primary_10_1097_WCO_0000000000001163 crossref_primary_10_1002_ana_25979 crossref_primary_10_1038_s41598_019_46415_1 crossref_primary_10_1007_s11065_023_09607_1 crossref_primary_10_1177_14713012251356588 crossref_primary_10_1111_neup_12859 crossref_primary_10_1212_CPJ_0000000000000959 crossref_primary_10_1001_jamaneurol_2025_3307 crossref_primary_10_1097_WNN_0000000000000273 crossref_primary_10_1212_WNL_0000000000200750 crossref_primary_10_1016_j_nicl_2017_05_018 crossref_primary_10_1371_journal_pone_0236384 crossref_primary_10_7759_cureus_90325 crossref_primary_10_1038_s41598_025_90116_x crossref_primary_10_1007_s11065_025_09659_5 crossref_primary_10_1007_s00415_018_8762_6 crossref_primary_10_1016_S1634_7072_21_45320_1 crossref_primary_10_1016_j_nicl_2024_103639 crossref_primary_10_1111_1460_6984_12798 crossref_primary_10_3389_fpsyg_2022_887591 crossref_primary_10_1080_13554794_2025_2537955 crossref_primary_10_1016_j_cortex_2019_01_021 crossref_primary_10_1080_02687038_2018_1447640 crossref_primary_10_1097_CM9_0000000000001424 crossref_primary_10_1080_13803395_2024_2410207 crossref_primary_10_1186_s40478_025_02077_x crossref_primary_10_3233_ADR_230010 crossref_primary_10_1016_S1634_7072_19_42020_5 crossref_primary_10_1111_ene_70275 crossref_primary_10_1080_02687038_2019_1659935 crossref_primary_10_1097_WCO_0000000000000571 crossref_primary_10_1002_dad2_12148 crossref_primary_10_1093_brain_awab410 crossref_primary_10_1002_mdc3_12796 crossref_primary_10_1080_02687038_2018_1490388 crossref_primary_10_3390_life12070933 crossref_primary_10_1080_14737159_2020_1731306 crossref_primary_10_1093_brain_awad396 crossref_primary_10_1080_13554794_2019_1690665 crossref_primary_10_1017_S1355617717000984 crossref_primary_10_1002_hbm_26388 crossref_primary_10_1080_13554794_2019_1581225 crossref_primary_10_1080_13554794_2019_1609522 crossref_primary_10_1002_alz_12794 crossref_primary_10_1016_j_neurobiolaging_2020_11_012 crossref_primary_10_2967_jnumed_124_268756 crossref_primary_10_1007_s11910_021_01097_z crossref_primary_10_1186_s12883_018_1115_3 crossref_primary_10_3233_JAD_210688 crossref_primary_10_1212_WNL_0000000000009760 crossref_primary_10_1212_WNL_0000000000200864 crossref_primary_10_1038_nrneurol_2017_96 crossref_primary_10_1016_j_disamonth_2023_101545 crossref_primary_10_3389_fnins_2019_00298 crossref_primary_10_1007_s13311_021_01101_x crossref_primary_10_1002_alz_13777 crossref_primary_10_1097_WCO_0000000000000792 crossref_primary_10_3389_fneur_2022_1049113 crossref_primary_10_1002_alz_13415 crossref_primary_10_3389_fneur_2018_00692 crossref_primary_10_1097_WCO_0000000000000673 crossref_primary_10_3390_diagnostics13101682 crossref_primary_10_12688_f1000research_21184_1 crossref_primary_10_1093_cercor_bhy069 crossref_primary_10_1212_WNL_0000000000004860 crossref_primary_10_1016_j_ynirp_2025_100242 crossref_primary_10_1212_WNL_0000000000209924 crossref_primary_10_1007_s12035_020_02035_9 crossref_primary_10_1007_s00401_019_02036_6 crossref_primary_10_1155_2022_6075511 crossref_primary_10_1016_j_cortex_2023_08_007 crossref_primary_10_3233_ADR_230168 crossref_primary_10_1080_02687038_2024_2343457 crossref_primary_10_1212_WNL_0000000000004500 crossref_primary_10_1044_2018_JSLHR_L_18_0144 crossref_primary_10_3389_fnhum_2025_1526554 crossref_primary_10_1016_j_neurobiolaging_2022_02_007 crossref_primary_10_1134_S0362119720080137 crossref_primary_10_3390_brainsci14040391 crossref_primary_10_3390_ijms241411732 crossref_primary_10_3233_JAD_201132 crossref_primary_10_3390_ijms23158487 crossref_primary_10_1080_02687038_2021_1897079 crossref_primary_10_1093_brain_awaa245 crossref_primary_10_1016_j_cortex_2019_05_007 crossref_primary_10_1212_WNL_0000000000006913 crossref_primary_10_3390_brainsci12070910 crossref_primary_10_1002_ana_25333 crossref_primary_10_1007_s11682_019_00253_x crossref_primary_10_1186_s40478_023_01629_3 crossref_primary_10_1212_WNL_0000000000004041 crossref_primary_10_1186_s13195_022_00974_0 crossref_primary_10_1002_brb3_2500 crossref_primary_10_1016_j_cortex_2018_11_025 crossref_primary_10_1111_psyg_12665 crossref_primary_10_3390_geriatrics10010002 crossref_primary_10_1044_2020_AJSLP_20_00007 crossref_primary_10_1016_j_cortex_2024_04_008 crossref_primary_10_1016_j_neurol_2020_12_001 crossref_primary_10_1007_s10072_025_08100_2 crossref_primary_10_1016_j_neubiorev_2025_106264 crossref_primary_10_1016_j_cortex_2019_12_025 crossref_primary_10_1016_j_bandl_2019_104676 crossref_primary_10_2496_hbfr_42_258 crossref_primary_10_1186_s13256_021_02867_6 crossref_primary_10_1016_j_clinph_2020_03_003 crossref_primary_10_1002_ana_25465 crossref_primary_10_1016_j_neurobiolaging_2020_04_010 crossref_primary_10_1016_j_cortex_2019_01_006 crossref_primary_10_1093_brain_awae391 crossref_primary_10_1053_j_semnuclmed_2020_12_004 crossref_primary_10_1038_s41598_023_41922_8 crossref_primary_10_1080_02687038_2020_1852002 crossref_primary_10_1016_j_nicl_2025_103789 crossref_primary_10_1111_nan_12535 crossref_primary_10_1007_s00259_018_4125_x crossref_primary_10_31083_j_fbl2801021 crossref_primary_10_1080_13554794_2020_1795204 crossref_primary_10_3389_fneur_2019_00485 crossref_primary_10_1007_s11604_024_01612_5 crossref_primary_10_1093_brain_awaa221 crossref_primary_10_1212_WNL_0000000000008879
Cites_doi	10.1038/nrneurol.2009.216 10.1212/WNL.0b013e3181c7198e 10.1002/hbm.22794 10.3233/JAD-150334 10.1145/1961189.1961199 10.1002/ana.21388 10.1371/journal.pgen.1004211 10.1002/mds.25737 10.1212/01.wnl.0000436070.28137.7b 10.1016/j.bandl.2013.02.003 10.1007/s00415-015-7845-x 10.1093/brain/awu024 10.1016/j.neuroimage.2009.05.085 10.1007/s00401-009-0612-2 10.1016/j.neurobiolaging.2015.10.017 10.1136/jnnp-2012-304418 10.1016/S0197-4580(97)00057-2 10.1016/j.neuroimage.2007.07.007 10.1002/ana.21451 10.1016/j.neuron.2009.03.024 10.1016/j.neurobiolaging.2010.05.020 10.1093/brain/awl078 10.1073/pnas.1301175110 10.1186/s40478-015-0190-6 10.1212/WNL.0000000000000031 10.3233/JAD-151063 10.1212/01.wnl.0000320506.79811.da 10.1093/brain/awh628 10.1212/WNL.0b013e318202038c 10.1016/j.cortex.2015.10.012 10.1136/jnnp-2013-306948 10.1212/WNL.0b013e31823b9c5e 10.1002/ana.10825 10.1093/brain/awp248 10.1097/WNN.0000000000000060 10.1212/WNL.47.5.1113 10.1093/brain/awr198 10.1093/brain/awh598 10.1016/j.neuroimage.2005.02.018 10.1212/WNL.0b013e31821103e6 10.1093/brain/awt266 10.1371/journal.pone.0031302 10.4061/2011/546871 10.1007/s00401-013-1238-y 10.1002/ana.20700 10.1016/j.cortex.2015.03.011 10.1097/00146965-200312000-00002 10.1093/brain/awr216 10.1016/j.celrep.2013.06.007 10.1093/brain/awt163
ContentType	Journal Article
Copyright	2017 American Neurological Association 2017 American Neurological Association.
Copyright_xml	– notice: 2017 American Neurological Association – notice: 2017 American Neurological Association.
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7U7 C1K K9. 7X8 5PM
DOI	10.1002/ana.24885
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Toxicology Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE Neurosciences Abstracts
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1531-8249
EndPage	443
ExternalDocumentID	PMC5421819 4321141153 28133816 10_1002_ana_24885 ANA24885
Genre	article Journal Article
GrantInformation_xml	– fundername: State of California funderid: DHS04‐35516 – fundername: National Institute on Aging funderid: P50 AG03006 ; P50 AG023501 ; P01 AG019724 – fundername: Larry L. Hillblom Foundation – fundername: John Douglas French Alzheimer's Foundation – fundername: Koret Family Foundation – fundername: Alzheimer's Disease Center of California funderid: 03‐75271 – fundername: Consortium for Frontotemporal Dementia Research – fundername: National Institute on Deafness and Other Communication Disorders funderid: K24 DC015544 – fundername: National Institute of Neurological Disorders and Stroke funderid: R01 NS050915 – fundername: McBean Family Foundation – fundername: NIDCD NIH HHS grantid: K24 DC015544 – fundername: NIA NIH HHS grantid: K23 AG048291 – fundername: NIDCD NIH HHS grantid: R01 DC013270 – fundername: NIA NIH HHS grantid: R01 AG045611 – fundername: NIA NIH HHS grantid: P01 AG019724 – fundername: NIA NIH HHS grantid: U01 AG052943 – fundername: NIA NIH HHS grantid: R01 AG038791 – fundername: NINDS NIH HHS grantid: R01 NS050915 – fundername: NINDS NIH HHS grantid: U54 NS092089 – fundername: NIA NIH HHS grantid: P50 AG023501
GroupedDBID	--- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1CY 1L6 1OB 1OC 1ZS 23M 2QL 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEJM AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AAQQT AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABIVO ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBMB ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACRZS ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFAZI AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE AJJEV ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM EBS EJD EMOBN F00 F01 F04 F5P F8P FEDTE FUBAC FYBCS G-S G.N GNP GODZA GOZPB GRPMH H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KBYEO KD1 KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LXL LXN LXY LYRES M6M MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ NNB O66 O9- OHT OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.- Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWD RWI RX1 SAMSI SJN SUPJJ TEORI UB1 V2E V8K V9Y VH1 W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 XJT XPP XSW XV2 YOC YQJ ZGI ZRF ZRR ZXP ZZTAW ~IA ~WT ~X8 AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7TK 7U7 C1K K9. 7X8 5PM
ID	FETCH-LOGICAL-c5075-61e1792475bce3dbd5d6ae28e18f63389fecedc16aa5bc1c6aee9defde6f5bd13
IEDL.DBID	DRFUL
ISICitedReferencesCount	267
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000397280100012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0364-5134 1531-8249
IngestDate	Tue Nov 04 01:59:42 EST 2025 Thu Oct 02 05:36:43 EDT 2025 Sun Nov 09 14:42:01 EST 2025 Thu Dec 04 04:12:52 EST 2025 Mon Jul 21 05:55:48 EDT 2025 Tue Nov 18 21:55:51 EST 2025 Sat Nov 29 03:41:25 EST 2025 Wed Jan 22 16:59:11 EST 2025
IsPeerReviewed	true
IsScholarly	true
Issue	3
Language	English
License	http://onlinelibrary.wiley.com/termsAndConditions#vor 2017 American Neurological Association.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c5075-61e1792475bce3dbd5d6ae28e18f63389fecedc16aa5bc1c6aee9defde6f5bd13
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
PMID	28133816
PQID	1880600445
PQPubID	946345
PageCount	14
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_5421819 proquest_miscellaneous_1888979660 proquest_miscellaneous_1862945015 proquest_journals_1880600445 pubmed_primary_28133816 crossref_citationtrail_10_1002_ana_24885 crossref_primary_10_1002_ana_24885 wiley_primary_10_1002_ana_24885_ANA24885
PublicationCentury	2000
PublicationDate	March 2017 2017-03-00 2017-Mar 20170301
PublicationDateYYYYMMDD	2017-03-01
PublicationDate_xml	– month: 03 year: 2017 text: March 2017
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States – name: Minneapolis
PublicationTitle	Annals of neurology
PublicationTitleAlternate	Ann Neurol
PublicationYear	2017
Publisher	Wiley Subscription Services, Inc
Publisher_xml	– name: Wiley Subscription Services, Inc
References	2015; 262 2009; 47 2010; 75 2015; 36 2013; 4 2009; 62 2011; 2 2015; 3 2013; 127 2013; 84 2015; 74 2006; 59 2016; 53 2011; 77 2011; 76 2003; 16 2014; 29 2014; 85 2005; 26 2016; 38 2012; 33 2014; 82 2008; 71 2011; 134 2014; 137 2007; 38 2004; 55 2011; 2011 2015; 67 2014; 127 2015; 47 2015; 28 2010; 119 2005; 128 2010; 133 1997; 18 2013; 136 2013; 81 2008; 63 2013; 110 2008; 64 1996; 47 2012; 7 2006; 129 2010; 74 2010; 6 2014; 10 e_1_2_8_28_1 e_1_2_8_24_1 e_1_2_8_47_1 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_3_1 e_1_2_8_5_1 e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_41_1 e_1_2_8_17_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_32_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_51_1 e_1_2_8_29_1 e_1_2_8_25_1 e_1_2_8_46_1 e_1_2_8_27_1 e_1_2_8_48_1 National Institute on Aging, Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease (e_1_2_8_30_1) 1997; 18 e_1_2_8_2_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_23_1 e_1_2_8_44_1 e_1_2_8_40_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_50_1 26194195 - J Neurol. 2015 Oct;262(10):2336-45 21908872 - Brain. 2011 Sep;134(Pt 9):2565-81 16374817 - Ann Neurol. 2006 Jan;59(1):156-65 23690619 - Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9535-40 16613895 - Brain. 2006 Jun;129(Pt 6):1385-98 24407427 - Acta Neuropathol. 2014 Mar;127(3):423-39 26102999 - Cogn Behav Neurol. 2015 Jun;28(2):92-7 22131541 - Neurology. 2011 Dec 6;77(23 ):2034-42 9330978 - Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2 24603599 - PLoS Genet. 2014 Mar 06;10(3):e1004211 25955499 - Cortex. 2015 Jun;67:122-33 14991811 - Ann Neurol. 2004 Mar;55(3):335-46 19940270 - Neurology. 2010 Jan 5;74(1):42-9 26673947 - Cortex. 2016 Jan;74:149-57 24108322 - Brain. 2013 Nov;136(Pt 11):3474-88 26401773 - J Alzheimers Dis. 2015;47(4):939-54 14665820 - Cogn Behav Neurol. 2003 Dec;16(4):211-8 18633132 - Neurology. 2008 Oct 14;71(16):1227-34 21325651 - Neurology. 2011 Mar 15;76(11):1006-14 16033782 - Brain. 2005 Sep;128(Pt 9):1996-2005 25821176 - Hum Brain Mapp. 2015 Jul;36(7):2602-14 19376066 - Neuron. 2009 Apr 16;62(1):42-52 21172843 - Neurology. 2010 Dec 14;75(24):2204-11 16195246 - Brain. 2005 Nov;128(Pt 11):2612-25 26827646 - Neurobiol Aging. 2016 Feb;38:82-92 19805492 - Brain. 2010 Jan;133(Pt 1):300-6 23475817 - J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):949-55 23541297 - Brain Lang. 2013 Nov;127(2):127-34 22312444 - PLoS One. 2012;7(2):e31302 23820597 - Brain. 2013 Aug;136(Pt 8):2619-28 15955494 - Neuroimage. 2005 Jul 1;26(3):839-51 8909416 - Neurology. 1996 Nov;47(5):1113-24 21760989 - Int J Alzheimers Dis. 2011;2011:546871 24142474 - Neurology. 2013 Nov 19;81(21):1832-9 20139998 - Nat Rev Neurol. 2010 Feb;6(2):88-97 23831027 - Cell Rep. 2013 Jul 11;4(1):124-34 18991338 - Ann Neurol. 2008 Oct;64(4):388-401 24574501 - Brain. 2014 Apr;137(Pt 4):1176-92 19924424 - Acta Neuropathol. 2010 Jan;119(1):1-4 20580129 - Neurobiol Aging. 2012 Apr;33(4):744-52 24421286 - J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):865-70 24323617 - Mov Disord. 2014 Feb;29(2):266-9 19501654 - Neuroimage. 2009 Oct 1;47(4):1558-67 25853458 - Acta Neuropathol Commun. 2015 Apr 03;3:19 27104894 - J Alzheimers Dis. 2016 Apr 19;53(1):135-42 18412267 - Ann Neurol. 2008 Jun;63(6):709-19 17761438 - Neuroimage. 2007 Oct 15;38(1):95-113 24353332 - Neurology. 2014 Jan 21;82(3):239-47 21908392 - Brain. 2011 Oct;134(Pt 10):3030-43
References_xml	– volume: 29 start-page: 266 year: 2014 end-page: 269 article-title: Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy publication-title: Mov Disord – volume: 53 start-page: 135 year: 2016 end-page: 142 article-title: Dementia and rapid mortality: who is at risk? publication-title: J Alzheimers Dis – volume: 127 start-page: 127 year: 2013 end-page: 134 article-title: Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer's disease presenting as logopenic progressive aphasia publication-title: Brain Lang – volume: 110 start-page: 9535 year: 2013 end-page: 9540 article-title: Brain homogenates from human tauopathies induce tau inclusions in mouse brain publication-title: Proc Natl Acad Sci U S A – volume: 36 start-page: 2602 year: 2015 end-page: 2614 article-title: MRI signatures of the frontotemporal lobar degeneration continuum publication-title: Hum Brain Mapp – volume: 136 start-page: 2619 issue: pt 8 year: 2013 end-page: 2628 article-title: A novel frontal pathway underlies verbal fluency in primary progressive aphasia publication-title: Brain – volume: 133 start-page: 300 issue: pt 1 year: 2010 end-page: 306 article-title: Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases publication-title: Brain – volume: 7 start-page: e31302 year: 2012 article-title: Trans‐synaptic spread of tau pathology in vivo publication-title: PLoS One – volume: 28 start-page: 92 year: 2015 end-page: 97 article-title: Temporal variant frontotemporal dementia is associated with globular glial tauopathy publication-title: Cogn Behav Neurol – volume: 47 start-page: 1113 year: 1996 end-page: 1124 article-title: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop publication-title: Neurology – volume: 84 start-page: 949 year: 2013 end-page: 955 article-title: White matter imaging helps dissociate tau from TDP‐43 in frontotemporal lobar degeneration publication-title: J Neurol Neurosurg Psychiatry – volume: 81 start-page: 1832 year: 2013 end-page: 1839 article-title: Classification and pathology of primary progressive aphasia publication-title: Neurology – volume: 134 start-page: 3030 issue: pt 10 year: 2011 end-page: 3043 article-title: Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using beta‐amyloid imaging publication-title: Brain – volume: 77 start-page: 2034 year: 2011 end-page: 2042 article-title: Amyloid vs FDG‐PET in the differential diagnosis of AD and FTLD publication-title: Neurology – volume: 76 start-page: 1006 year: 2011 end-page: 1014 article-title: Classification of primary progressive aphasia and its variants publication-title: Neurology – volume: 136 start-page: 3474 issue: pt 11 year: 2013 end-page: 3488 article-title: Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation publication-title: Brain – volume: 3 start-page: 19 year: 2015 article-title: A novel mutation P112H in the TARDBP gene associated with frontotemporal lobar degeneration without motor neuron disease and abundant neuritic amyloid plaques publication-title: Acta Neuropathol Commun – volume: 64 start-page: 388 year: 2008 end-page: 401 article-title: Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia publication-title: Ann Neurol – volume: 129 start-page: 1385 issue: pt 6 year: 2006 end-page: 1398 article-title: Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech publication-title: Brain – volume: 18 start-page: S1 issue: 4 suppl year: 1997 end-page: S2 article-title: Consensus recommendations for the postmortem diagnosis of Alzheimer's disease publication-title: Neurobiol Aging – volume: 75 start-page: 2204 year: 2010 end-page: 2211 article-title: TDP‐43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia publication-title: Neurology – volume: 16 start-page: 211 year: 2003 end-page: 218 article-title: Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease publication-title: Cogn Behav Neurol – volume: 67 start-page: 122 year: 2015 end-page: 133 article-title: Is the logopenic‐variant of primary progressive aphasia a unitary disorder? publication-title: Cortex – volume: 119 start-page: 1 year: 2010 end-page: 4 article-title: Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update publication-title: Acta Neuropathol – volume: 2 start-page: 1 year: 2011 end-page: 27 article-title: LIBSVM: a library for support vector machines publication-title: ACM Trans Intell Syst Technol – volume: 128 start-page: 1996 issue: pt 9 year: 2005 end-page: 2005 article-title: The evolution and pathology of frontotemporal dementia publication-title: Brain – volume: 47 start-page: 939 year: 2015 end-page: 954 article-title: Applying automated MR‐based diagnostic methods to the memory clinic: a prospective study publication-title: J Alzheimers Dis – volume: 62 start-page: 42 year: 2009 end-page: 52 article-title: Neurodegenerative diseases target large‐scale human brain networks publication-title: Neuron – volume: 55 start-page: 335 year: 2004 end-page: 346 article-title: Cognition and anatomy in three variants of primary progressive aphasia publication-title: Ann Neurol – volume: 71 start-page: 1227 year: 2008 end-page: 1234 article-title: The logopenic/phonological variant of primary progressive aphasia publication-title: Neurology – volume: 47 start-page: 1558 year: 2009 end-page: 1567 article-title: Automated MRI‐based classification of primary progressive aphasia variants publication-title: Neuroimage – volume: 2011 start-page: 546871 year: 2011 article-title: Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia publication-title: Int J Alzheimers Dis – volume: 38 start-page: 82 year: 2016 end-page: 92 article-title: Distinctive pathological mechanisms involved in primary progressive aphasias publication-title: Neurobiol Aging – volume: 38 start-page: 95 year: 2007 end-page: 113 article-title: A fast diffeomorphic image registration algorithm publication-title: Neuroimage – volume: 26 start-page: 839 year: 2005 end-page: 851 article-title: Unified segmentation publication-title: Neuroimage – volume: 74 start-page: 149 year: 2015 end-page: 157 article-title: Two insular regions are differentially involved in behavioral variant FTD and nonfluent/agrammatic variant PPA publication-title: Cortex – volume: 137 start-page: 1176 issue: pt 4 year: 2014 end-page: 1192 article-title: Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia publication-title: Brain – volume: 74 start-page: 42 year: 2010 end-page: 49 article-title: Prediction of pathology in primary progressive language and speech disorders publication-title: Neurology – volume: 127 start-page: 423 year: 2014 end-page: 439 article-title: Sequential distribution of pTDP‐43 pathology in behavioral variant frontotemporal dementia (bvFTD) publication-title: Acta Neuropathol – volume: 4 start-page: 124 year: 2013 end-page: 134 article-title: Prion‐like properties of pathological TDP‐43 aggregates from diseased brains publication-title: Cell Rep – volume: 33 start-page: 744 year: 2012 end-page: 752 article-title: Alzheimer's pathology in primary progressive aphasia publication-title: Neurobiol Aging – volume: 82 start-page: 239 year: 2014 end-page: 247 article-title: In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathology publication-title: Neurology – volume: 262 start-page: 2336 year: 2015 end-page: 2345 article-title: A multimodal neuroimaging study of a case of crossed nonfluent/agrammatic primary progressive aphasia publication-title: J Neurol – volume: 59 start-page: 156 year: 2006 end-page: 165 article-title: Clinical and pathological characterization of progressive aphasia publication-title: Ann Neurol – volume: 134 start-page: 2565 issue: pt 9 year: 2011 end-page: 2581 article-title: Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration publication-title: Brain – volume: 63 start-page: 709 year: 2008 end-page: 719 article-title: Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia publication-title: Ann Neurol – volume: 85 start-page: 865 year: 2014 end-page: 870 article-title: New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications publication-title: J Neurol Neurosurg Psychiatry – volume: 6 start-page: 88 year: 2010 end-page: 97 article-title: Primary progressive aphasia: clinicopathological correlations publication-title: Nat Rev Neurol – volume: 10 start-page: e1004211 year: 2014 article-title: An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy publication-title: PLoS Genet – volume: 128 start-page: 2612 issue: pt 11 year: 2005 end-page: 2625 article-title: Neuroanatomical correlates of behavioural disorders in dementia publication-title: Brain – ident: e_1_2_8_6_1 doi: 10.1038/nrneurol.2009.216 – ident: e_1_2_8_9_1 doi: 10.1212/WNL.0b013e3181c7198e – ident: e_1_2_8_45_1 doi: 10.1002/hbm.22794 – ident: e_1_2_8_22_1 doi: 10.3233/JAD-150334 – ident: e_1_2_8_36_1 doi: 10.1145/1961189.1961199 – ident: e_1_2_8_4_1 doi: 10.1002/ana.21388 – ident: e_1_2_8_27_1 doi: 10.1371/journal.pgen.1004211 – ident: e_1_2_8_23_1 doi: 10.1002/mds.25737 – ident: e_1_2_8_7_1 doi: 10.1212/01.wnl.0000436070.28137.7b – ident: e_1_2_8_13_1 doi: 10.1016/j.bandl.2013.02.003 – ident: e_1_2_8_37_1 doi: 10.1007/s00415-015-7845-x – ident: e_1_2_8_5_1 doi: 10.1093/brain/awu024 – ident: e_1_2_8_24_1 doi: 10.1016/j.neuroimage.2009.05.085 – ident: e_1_2_8_29_1 doi: 10.1007/s00401-009-0612-2 – ident: e_1_2_8_15_1 doi: 10.1016/j.neurobiolaging.2015.10.017 – ident: e_1_2_8_44_1 doi: 10.1136/jnnp-2012-304418 – volume: 18 start-page: S1 issue: 4 year: 1997 ident: e_1_2_8_30_1 article-title: Consensus recommendations for the postmortem diagnosis of Alzheimer's disease publication-title: Neurobiol Aging doi: 10.1016/S0197-4580(97)00057-2 – ident: e_1_2_8_35_1 doi: 10.1016/j.neuroimage.2007.07.007 – ident: e_1_2_8_19_1 doi: 10.1002/ana.21451 – ident: e_1_2_8_50_1 doi: 10.1016/j.neuron.2009.03.024 – ident: e_1_2_8_14_1 doi: 10.1016/j.neurobiolaging.2010.05.020 – ident: e_1_2_8_10_1 doi: 10.1093/brain/awl078 – ident: e_1_2_8_47_1 doi: 10.1073/pnas.1301175110 – ident: e_1_2_8_26_1 doi: 10.1186/s40478-015-0190-6 – ident: e_1_2_8_38_1 doi: 10.1212/WNL.0000000000000031 – ident: e_1_2_8_51_1 doi: 10.3233/JAD-151063 – ident: e_1_2_8_40_1 doi: 10.1212/01.wnl.0000320506.79811.da – ident: e_1_2_8_43_1 doi: 10.1093/brain/awh628 – ident: e_1_2_8_17_1 doi: 10.1212/WNL.0b013e318202038c – ident: e_1_2_8_32_1 doi: 10.1016/j.cortex.2015.10.012 – ident: e_1_2_8_3_1 doi: 10.1136/jnnp-2013-306948 – ident: e_1_2_8_41_1 doi: 10.1212/WNL.0b013e31823b9c5e – ident: e_1_2_8_25_1 doi: 10.1002/ana.10825 – ident: e_1_2_8_18_1 doi: 10.1093/brain/awp248 – ident: e_1_2_8_16_1 doi: 10.1097/WNN.0000000000000060 – ident: e_1_2_8_31_1 doi: 10.1212/WNL.47.5.1113 – ident: e_1_2_8_8_1 doi: 10.1093/brain/awr198 – ident: e_1_2_8_12_1 doi: 10.1093/brain/awh598 – ident: e_1_2_8_34_1 doi: 10.1016/j.neuroimage.2005.02.018 – ident: e_1_2_8_2_1 doi: 10.1212/WNL.0b013e31821103e6 – ident: e_1_2_8_21_1 doi: 10.1093/brain/awt266 – ident: e_1_2_8_46_1 doi: 10.1371/journal.pone.0031302 – ident: e_1_2_8_33_1 doi: 10.4061/2011/546871 – ident: e_1_2_8_49_1 doi: 10.1007/s00401-013-1238-y – ident: e_1_2_8_11_1 doi: 10.1002/ana.20700 – ident: e_1_2_8_42_1 doi: 10.1016/j.cortex.2015.03.011 – ident: e_1_2_8_28_1 doi: 10.1097/00146965-200312000-00002 – ident: e_1_2_8_20_1 doi: 10.1093/brain/awr216 – ident: e_1_2_8_48_1 doi: 10.1016/j.celrep.2013.06.007 – ident: e_1_2_8_39_1 doi: 10.1093/brain/awt163 – reference: 22131541 - Neurology. 2011 Dec 6;77(23 ):2034-42 – reference: 24421286 - J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):865-70 – reference: 23831027 - Cell Rep. 2013 Jul 11;4(1):124-34 – reference: 21908872 - Brain. 2011 Sep;134(Pt 9):2565-81 – reference: 24142474 - Neurology. 2013 Nov 19;81(21):1832-9 – reference: 19805492 - Brain. 2010 Jan;133(Pt 1):300-6 – reference: 21325651 - Neurology. 2011 Mar 15;76(11):1006-14 – reference: 24407427 - Acta Neuropathol. 2014 Mar;127(3):423-39 – reference: 17761438 - Neuroimage. 2007 Oct 15;38(1):95-113 – reference: 14665820 - Cogn Behav Neurol. 2003 Dec;16(4):211-8 – reference: 21760989 - Int J Alzheimers Dis. 2011;2011:546871 – reference: 20580129 - Neurobiol Aging. 2012 Apr;33(4):744-52 – reference: 9330978 - Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2 – reference: 24353332 - Neurology. 2014 Jan 21;82(3):239-47 – reference: 18991338 - Ann Neurol. 2008 Oct;64(4):388-401 – reference: 19940270 - Neurology. 2010 Jan 5;74(1):42-9 – reference: 24323617 - Mov Disord. 2014 Feb;29(2):266-9 – reference: 16195246 - Brain. 2005 Nov;128(Pt 11):2612-25 – reference: 19376066 - Neuron. 2009 Apr 16;62(1):42-52 – reference: 16374817 - Ann Neurol. 2006 Jan;59(1):156-65 – reference: 23820597 - Brain. 2013 Aug;136(Pt 8):2619-28 – reference: 23541297 - Brain Lang. 2013 Nov;127(2):127-34 – reference: 20139998 - Nat Rev Neurol. 2010 Feb;6(2):88-97 – reference: 18412267 - Ann Neurol. 2008 Jun;63(6):709-19 – reference: 24574501 - Brain. 2014 Apr;137(Pt 4):1176-92 – reference: 25821176 - Hum Brain Mapp. 2015 Jul;36(7):2602-14 – reference: 22312444 - PLoS One. 2012;7(2):e31302 – reference: 8909416 - Neurology. 1996 Nov;47(5):1113-24 – reference: 24603599 - PLoS Genet. 2014 Mar 06;10(3):e1004211 – reference: 26194195 - J Neurol. 2015 Oct;262(10):2336-45 – reference: 21908392 - Brain. 2011 Oct;134(Pt 10):3030-43 – reference: 23690619 - Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9535-40 – reference: 26673947 - Cortex. 2016 Jan;74:149-57 – reference: 26102999 - Cogn Behav Neurol. 2015 Jun;28(2):92-7 – reference: 16033782 - Brain. 2005 Sep;128(Pt 9):1996-2005 – reference: 18633132 - Neurology. 2008 Oct 14;71(16):1227-34 – reference: 25955499 - Cortex. 2015 Jun;67:122-33 – reference: 21172843 - Neurology. 2010 Dec 14;75(24):2204-11 – reference: 25853458 - Acta Neuropathol Commun. 2015 Apr 03;3:19 – reference: 14991811 - Ann Neurol. 2004 Mar;55(3):335-46 – reference: 23475817 - J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):949-55 – reference: 15955494 - Neuroimage. 2005 Jul 1;26(3):839-51 – reference: 19501654 - Neuroimage. 2009 Oct 1;47(4):1558-67 – reference: 26827646 - Neurobiol Aging. 2016 Feb;38:82-92 – reference: 26401773 - J Alzheimers Dis. 2015;47(4):939-54 – reference: 24108322 - Brain. 2013 Nov;136(Pt 11):3474-88 – reference: 19924424 - Acta Neuropathol. 2010 Jan;119(1):1-4 – reference: 16613895 - Brain. 2006 Jun;129(Pt 6):1385-98 – reference: 27104894 - J Alzheimers Dis. 2016 Apr 19;53(1):135-42
SSID	ssj0009610
Score	2.640653
Snippet	Objective To characterize in vivo signatures of pathological diagnosis in a large cohort of patients with primary progressive aphasia (PPA) variants defined by... To characterize in vivo signatures of pathological diagnosis in a large cohort of patients with primary progressive aphasia (PPA) variants defined by current... Objective To characterize in vivo signatures of pathological diagnosis in a large cohort of patients with primary progressive aphasia (PPA) variants defined by...
SourceID	pubmedcentral proquest pubmed crossref wiley
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	430
SubjectTerms	Aged Aged, 80 and over Alzheimer Disease - classification Alzheimer Disease - pathology Alzheimer Disease - physiopathology Aphasia, Primary Progressive - classification Aphasia, Primary Progressive - pathology Aphasia, Primary Progressive - physiopathology Atrophy - pathology Female Frontotemporal Lobar Degeneration - classification Frontotemporal Lobar Degeneration - pathology Frontotemporal Lobar Degeneration - physiopathology Gray Matter - diagnostic imaging Humans Male Medical imaging Middle Aged Neuropathology Pathology Pick Disease of the Brain - pathology Pick Disease of the Brain - physiopathology Primary Progressive Nonfluent Aphasia - pathology Primary Progressive Nonfluent Aphasia - physiopathology Support Vector Machine tau Proteins - metabolism White Matter - diagnostic imaging
Title	Typical and atypical pathology in primary progressive aphasia variants
URI	https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fana.24885 https://www.ncbi.nlm.nih.gov/pubmed/28133816 https://www.proquest.com/docview/1880600445 https://www.proquest.com/docview/1862945015 https://www.proquest.com/docview/1888979660 https://pubmed.ncbi.nlm.nih.gov/PMC5421819
Volume	81
WOSCitedRecordID	wos000397280100012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1531-8249 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009610 issn: 0364-5134 databaseCode: DRFUL dateStart: 19990101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB58IV58P9YXUTx4qW7bJE3xtKiLB11EFPZW0ibFBamyr9_vTNqtLj4QvLVkWprJTPNNZvIF4MSPtJXCcK_Z1IHHcxN6ymDMowxiJB2aJjeOZ_Y26nRUtxvfz8DFZC9MyQ9RL7iRZ7j_NTm4TgfnH6ShutBnAZqfmIV52lSFkdf81UP76faDc1c6MgLKtHnCD_mEWKgZnNcPT09HXzDm11LJzxDWzUHtlX99_SosV9CTtUpbWYMZW6zD4l2VXN-ANsakNGRMF4bpYXVDRxa7pXfWK9hbyU3BXFUXFdCOLdNvz7QTk40x6qaimk14al8_Xt541TELXoZgUGDwaNErAx6JNLOhSY0wUttAWV_lEiPYOLcZKsCXWqOEn2GjjY3NjZW5SI0fbsFc8VrYHWBZyHMZyTQPLec0D4rIj_E9Vqlcay4bcDrRdpJVHOR0FMZLUrInBwnqJXF6acBxLVp17juh_cmQJZXvDRJimJOUqMbmo7oZvYZSIbqwryOSkUHMBWKh32SUiiNiL23AdmkF9ZcEimJ7HzsUTdlHLUCs3dMtRe_ZsXcLTqgqRlU4-_i5c0mr03IXu38X3YOlkHCHK5Lbh7lhf2QPYCEbD3uD_iHMRl11WLnJO0NzFvE
linkProvider	Wiley-Blackwell
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fT9swED6xFsFeYMCAMn4YxAMvgcaxHUfipWKrmGgrNBWJt8iNHVFpCghK__7dOWmg6jZN2lsiX6L4fBd_5zt_BjgNY-OUtCJotw0PRG6jQFuMebRFjGQi2xbW88z24sFA398nt0twOdsLU_JD1Atu5Bn-f00OTgvSF2-soaYw5xztT36AplBRrBvQ_Pqje9d7I91Vno2AUm2BDCMxYxZq84v64fn5aAFkLtZKvsewfhLqrv_f53-CtQp8sk5pLRuw5IpNWOlX6fUt6GJUSoPGTGGZmVQ3dGixX3xn44I9lewUzNd1UQnt1DHz9EB7MdkU424qq_kMd91vw6vroDpoIcgQDkoMHx36JRexHGUusiMrrTKOaxfqXGEMm-QuQw2EyhiUCDNsdIl1uXUqlyMbRtvQKB4Ltwssi0SuYjXKIycEzYQyDhN8j9M6N0aoFpzN1J1mFQs5HYbxMy35k3mKekm9XlpwUotWnfud0P5szNLK-15S4phTlKrG5uO6Gf2GkiGmcI-vJKN4IiSiob_JaJ3ExF_agp3SDOov4Zqi-xA7FM8ZSC1AvN3zLcX4wfN3S0G4KkFVeAP5c-fSzqDjL_b-XfQIVq-H_V7a-z64-QIfOaEQXzK3D43J86s7gOVsOhm_PB9W3vILUJcZ-A
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwED6NDk28wPhd2MAgHngJaxzbcSReqo0IRKkmxKS9RW581iqhrNq6_v3cOWlGtYGQeEvkSxSf7-LvfOfPAO_S3KHRXiWjkZOJCj5LrKeYx3rCSC7zI-Ujz-wkn07t6WlxvAUf13thWn6IfsGNPSP-r9nBceHDwTVrqGvcB0n2p-_AttKFVgPYPvpenkyuSXdNZCPgVFui00ytmYVG8qB_eHM-ugEyb9ZK_o5h4yRUPvi_z9-F-x34FOPWWh7CFjaPYOdbl15_DCVFpTxowjVeuGV3w4cWx8V3MW_EomWnELGui0toVyjc4oz3YooVxd1cVvMETspPPw4_J91BC0lNcFBT-Ijkl1LlelZj5mdee-NQWkxtMBTDFgFr0kBqnCOJtKZGLDwGjybomU-zpzBozht8DqLOVDC5mYUMleKZUOdpQe9Ba4Nzygzh_VrdVd2xkPNhGD-rlj9ZVqSXKuplCG970a5ztwntrces6rzvsmKOOcOpamp-0zeT33AyxDV4fsUyRhZKExr6m4y1Rc78pUN41ppB_yXScnSfUofyDQPpBZi3e7OlmZ9F_m6tGFcVpIpoIH_uXDWejuPFi38XfQ07x0dlNfky_foS7kkGIbFibg8Gy4sr3Ie79Wo5v7x41TnLL7gAGXM
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Typical+and+atypical+pathology+in+primary+progressive+aphasia+variants&rft.jtitle=Annals+of+neurology&rft.au=Spinelli%2C+Edoardo+G&rft.au=Mandelli%2C+Maria+Luisa&rft.au=Miller%2C+Zachary+A&rft.au=Santos-Santos%2C+Miguel+A&rft.date=2017-03-01&rft.issn=0364-5134&rft.eissn=1531-8249&rft.volume=81&rft.issue=3&rft.spage=430&rft.epage=443&rft_id=info:doi/10.1002%2Fana.24885&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0364-5134&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0364-5134&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0364-5134&client=summon